Suppr超能文献

使用脂质纳米载体将药物储备递送至过表达血小板衍生生长因子受体的胶质瘤细胞。

Delivery of a drug cache to glioma cells overexpressing platelet-derived growth factor receptor using lipid nanocarriers.

作者信息

Miller Kayla, Dixit Suraj, Bredlau Amy-Lee, Moore Alfred, McKinnon Emilie, Broome Ann-Marie

机构信息

Department of Radiology & Radiological Sciences, Medical University of South Carolina, 68 President Street, MSC 120/BEB 213, Charleston, SC 29425, USA.

Center for Biomedical Imaging, Medical University of South Carolina, Charleston, SC 29425, USA.

出版信息

Nanomedicine (Lond). 2016 Mar;11(6):581-95. doi: 10.2217/nnm.15.218. Epub 2016 Mar 22.

Abstract

AIM

Glioblastoma multiforme is a devastating disease with no curative options due to the difficulty in achieving sufficient quantities of effective chemotherapies into the tumor past the blood-brain barrier. Micelles loaded with temozolomide (TMZ) were designed to increase the delivery of this drug into the brain.

MATERIALS & METHODS: pH-responsive micelles composed of distearoyl phosphoethanolamine-PEG-2000-amine and N-palmitoyl homocysteine were surface-functionalized with PDGF peptide and Dylight 680 fluorophore.

RESULTS & CONCLUSION: PDGF-micelles containing TMZ have specific uptake and increased killing in glial cells compared with untargeted micelles. In vivo studies demonstrated selective accumulation of PDGF-micelles containing TMZ in orthotopic gliomas implanted in mice. Targeted micelle-based drug carrier systems hold potential for delivery of a wide variety of hydrophobic drugs thereby reducing its systemic toxicity.

摘要

目的

多形性胶质母细胞瘤是一种毁灭性疾病,由于难以越过血脑屏障将足够量的有效化疗药物输送到肿瘤中,因此没有治愈方案。设计负载替莫唑胺(TMZ)的胶束以增加该药物向脑内的递送。

材料与方法

由二硬脂酰磷脂酰乙醇胺-聚乙二醇-2000-胺和N-棕榈酰高半胱氨酸组成的pH响应性胶束用血小板衍生生长因子(PDGF)肽和DyLight 680荧光团进行表面功能化。

结果与结论

与未靶向的胶束相比,含TMZ的PDGF胶束在胶质细胞中具有特异性摄取并增强了杀伤作用。体内研究表明,含TMZ的PDGF胶束在植入小鼠的原位胶质瘤中具有选择性积累。基于靶向胶束的药物载体系统具有递送多种疏水性药物的潜力,从而降低其全身毒性。

相似文献

1
Delivery of a drug cache to glioma cells overexpressing platelet-derived growth factor receptor using lipid nanocarriers.
Nanomedicine (Lond). 2016 Mar;11(6):581-95. doi: 10.2217/nnm.15.218. Epub 2016 Mar 22.
2
Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma.
J Control Release. 2015 Jul 28;210:95-104. doi: 10.1016/j.jconrel.2015.05.272. Epub 2015 May 15.
3
A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.
J Control Release. 2015 Nov 28;218:29-35. doi: 10.1016/j.jconrel.2015.09.061. Epub 2015 Sep 30.
5
Antitumor effect of fibrin glue containing temozolomide against malignant glioma.
Cancer Sci. 2014 May;105(5):583-91. doi: 10.1111/cas.12397. Epub 2014 Apr 19.
6
Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth.
J Cancer Res Clin Oncol. 2012 Dec;138(12):2079-84. doi: 10.1007/s00432-012-1290-3. Epub 2012 Jul 24.
8
Determination of an optimal dosing schedule for combining Irinophore C™ and temozolomide in an orthotopic model of glioblastoma.
J Control Release. 2015 Dec 28;220(Pt A):348-357. doi: 10.1016/j.jconrel.2015.10.053. Epub 2015 Nov 1.
10
Liposomal temozolomide drug delivery using convection enhanced delivery.
J Control Release. 2017 Sep 10;261:138-146. doi: 10.1016/j.jconrel.2017.06.028. Epub 2017 Jun 27.

引用本文的文献

1
Neuroinflammation Treatment via Targeted Delivery of Nanoparticles.
Front Cell Neurosci. 2020 Sep 30;14:576037. doi: 10.3389/fncel.2020.576037. eCollection 2020.
2
UCNP-based Photoluminescent Nanomedicines for Targeted Imaging and Theranostics of Cancer.
Molecules. 2020 Sep 19;25(18):4302. doi: 10.3390/molecules25184302.
3
Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency.
Cancers (Basel). 2019 Jan 10;11(1):68. doi: 10.3390/cancers11010068.
5
A Critical Overview of Targeted Therapies for Glioblastoma.
Front Oncol. 2018 Oct 15;8:419. doi: 10.3389/fonc.2018.00419. eCollection 2018.
6
[Protective effect of exosome on organs after ischemia-reperfusion injury].
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2017 Jun 15;31(6):751-754. doi: 10.7507/1002-1892.201701104.

本文引用的文献

1
Nanoparticles for brain drug delivery.
ISRN Biochem. 2013 May 21;2013:238428. doi: 10.1155/2013/238428. eCollection 2013.
2
Drug and cell encapsulation: alternative delivery options for the treatment of malignant brain tumors.
Adv Drug Deliv Rev. 2014 Apr;67-68:142-53. doi: 10.1016/j.addr.2014.01.010. Epub 2014 Jan 31.
3
The potential of polymeric micelles in the context of glioblastoma therapy.
Front Pharmacol. 2013 Dec 30;4:157. doi: 10.3389/fphar.2013.00157.
4
Strategies for triggered drug release from tumor targeted liposomes.
Expert Opin Drug Deliv. 2013 Oct;10(10):1399-410. doi: 10.1517/17425247.2013.805742. Epub 2013 Jun 25.
5
Synergistic suppression of noscapine and conventional chemotherapeutics on human glioblastoma cell growth.
Acta Pharmacol Sin. 2013 Jul;34(7):930-8. doi: 10.1038/aps.2013.40. Epub 2013 May 27.
6
Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma.
J Neurooncol. 2013 Jul;113(3):467-77. doi: 10.1007/s11060-013-1139-x. Epub 2013 May 15.
7
Enhancing drug delivery for boron neutron capture therapy of brain tumors with focused ultrasound.
Neuro Oncol. 2013 Sep;15(9):1225-35. doi: 10.1093/neuonc/not052. Epub 2013 May 2.
8
Peptide arrays for development of PDGFRβ Affine molecules.
Mol Imaging Biol. 2013 Aug;15(4):391-400. doi: 10.1007/s11307-013-0616-0.
9
A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies.
Cancer Chemother Pharmacol. 2013 Mar;71(3):627-33. doi: 10.1007/s00280-012-2048-y. Epub 2012 Dec 30.
10
A simplified approach for the molecular classification of glioblastomas.
PLoS One. 2012;7(9):e45475. doi: 10.1371/journal.pone.0045475. Epub 2012 Sep 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验